Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Natale, R. B.; Thongprasert, S.; Greco, F. A.; Thomas, M.; Tsai, C.-M.; Sunpaweravong, P.; Ferry, D.; Mulatero, C.; Whorf, R.; Thompson, J.; Barlesi, F.; Langmuir, P.; Gogov, S.; Rowbottom, J. A.; Goss, G. D.

• Book ID: 125518994
• Publisher: American Society of Clinical Oncology
• Year: 2011
• Tongue: English
• Weight: 298 KB
• Volume: 29
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2010.28.5981